Barker RA - Search Results

1

Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?

Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, Burn DJ, O'Brien JT. Duncan GW, et al. Among authors: barker ra. Mov Disord. 2016 Jan;31(1):103-10. doi: 10.1002/mds.26312. Epub 2015 Jul 22. Mov Disord. 2016. PMID: 26202802

2

Repairing the brain in Parkinson's disease: where next?

Barker RA. Barker RA. Mov Disord. 2002 Mar;17(2):233-41. doi: 10.1002/mds.10091. Mov Disord. 2002. PMID: 11921107 Review. No abstract available.

3

Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.

Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P. Pavese N, et al. Among authors: barker ra. Brain. 2003 May;126(Pt 5):1127-35. doi: 10.1093/brain/awg119. Brain. 2003. PMID: 12690052

4

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Lewis SJ, et al. Among authors: barker ra. J Neurosci. 2003 Jul 16;23(15):6351-6. doi: 10.1523/JNEUROSCI.23-15-06351.2003. J Neurosci. 2003. PMID: 12867520 Free PMC article. Clinical Trial.

5

Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism.

Foltynie T, Goldberg TE, Lewis SG, Blackwell AD, Kolachana BS, Weinberger DR, Robbins TW, Barker RA. Foltynie T, et al. Among authors: barker ra. Mov Disord. 2004 Aug;19(8):885-91. doi: 10.1002/mds.20118. Mov Disord. 2004. PMID: 15300652

6

Huntington's disease patients have selective problems with insight.

Ho AK, Robbins AO, Barker RA. Ho AK, et al. Among authors: barker ra. Mov Disord. 2006 Mar;21(3):385-9. doi: 10.1002/mds.20739. Mov Disord. 2006. PMID: 16211608

7

Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. CNS Drugs. 2006;20(6):477-505. doi: 10.2165/00023210-200620060-00004. CNS Drugs. 2006. PMID: 16734499 Review.

8

Imaging microglial activation in Huntington's disease.

Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Tai YF, et al. Among authors: barker ra. Brain Res Bull. 2007 Apr 30;72(2-3):148-51. doi: 10.1016/j.brainresbull.2006.10.029. Epub 2006 Nov 27. Brain Res Bull. 2007. PMID: 17352938 Review.

9

Microglial activation in presymptomatic Huntington's disease gene carriers.

Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Tai YF, et al. Among authors: barker ra. Brain. 2007 Jul;130(Pt 7):1759-66. doi: 10.1093/brain/awm044. Epub 2007 Mar 30. Brain. 2007. PMID: 17400599

10

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. J Neurosci. 2007 May 2;27(18):4832-8. doi: 10.1523/JNEUROSCI.0774-07.2007. J Neurosci. 2007. PMID: 17475791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters